The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
Open accessAbstract
TGF-β can be a potent suppressor of lymphocyte effector cell functions and can mediate these effects via distinct molecular pathways. The role of TGF-β in regulating CD16-mediated NK cell IFN-γ production and antibody-dependent cellular cytotoxicity (ADCC) is unclear, as are the signaling pathways that may be utilized. Treatment of primary human NK cells with TGF-β inhibited IFN-γ production induced by CD16 activation with or without IL-12 or IL-2, and it did so without affecting the phosphorylation/activation of MAP kinases ERK and p38, as well as STAT4. TGF-β treatment induced SMAD3 phosphorylation, and ectopic overexpression of SMAD3 resulted in a significant decrease in IFN-γ gene expression following CD16 activation with or without IL-12 or IL-2. Likewise, NK cells obtained from smad3−/− mice produced more IFN-γ in response to CD16 activation plus IL-12 when compared with NK cells obtained from wild-type mice. Coactivation of human NK cells via CD16 and IL-12 induced expression of T-BET, the positive regulator of IFN-γ, and T-BET was suppressed by TGF-β and by SMAD3 overexpression. An extended treatment of primary NK cells with TGF-β was required to inhibit ADCC, and it did so by inhibiting granzyme A and granzyme B expression. This effect was accentuated in cells overexpressing SMAD3. Collectively, our results indicate that TGF-β inhibits CD16-mediated human NK cell IFN-γ production and ADCC, and these effects are mediated via SMAD3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Self-citationThe biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Self-citationBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Self-citationTGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., & Caligiuri, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4511 · Cited by 652
Self-citationIL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
Ahmadzadeh, M., & Rosenberg, S. A. (2006) · Blood · doi:10.1182/blood-2005-06-2399 · Cited by 632
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., & Caligiuri, M. A. (2002) · Blood · doi:10.1182/blood-2002-02-0350 · Cited by 491
Self-citationZhang, W., Gordon, M., Schultheis, A. M., Yang, D. Y., Nagashima, F., Azuma, M., Chang, H.-M., Borucka, E., Lurje, G., Sherrod, A. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8021 · Cited by 482
Laouar, Y., Sutterwala, F. S., Gorelik, L., & Flavell, R. A. (2005) · Nature Immunology · doi:10.1038/ni1197 · Cited by 451
Rituximab-Dependent Cytotoxicity by Natural Killer Cells
Dall’Ozzo, S., Tartas, S., Paintaud, G., Cartron, G., Colombat, P., Bardos, P., Watier, H., & Thibault, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2862 · Cited by 434
Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346
Signal Transduction during Natural Killer Cell Activation: Inside the Mind of a Killer
Leibson, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80441-0 · Cited by 292
Yu, J., Wei, M., Becknell, B., Trotta, R., Liu, S., Boyd, Z., Jaung, M. S., Blaser, B. W., Sun, J., Benson, D. M., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.016 · Cited by 279
Self-citationRegulation of NK cell functions by TGF-β 1
Bellone, G., Aste-Amezaga, M., Trinchieri, G., & Rodeck, U. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1066 · Cited by 243
BCR/ABL activates mdm2 mRNA translation via the La antigen
Trotta, R., Vignudelli, T., Candini, O., Intine, R. V., Pecorari, L., Guerzoni, C., Santilli, G., Byrom, M. W., Goldoni, S., Ford, L. P., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00020-5 · Cited by 217
Self-citationLitzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15950 · Cited by 180
Carson, W. E., Parihar, R., Lindemann, M. J., Personeni, N., Dierksheide, J. E., Meropol, N. J., Baselga, J. M., & Caligiuri, M. A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j · Cited by 175
Self-citationNatural Killer Cells Produce T Cell–Recruiting Chemokines in Response to Antibody-Coated Tumor Cells
Roda, J. M., Parihar, R., Magro, C., Nuovo, G. J., Tridandapani, S., & Carson, W. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2429 · Cited by 165
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215950 · Cited by 164
TGF-β Inhibits IL-12-Induced Activation of Jak-STAT Pathway in T Lymphocytes
Bright, J. J., & Sriram, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1772 · Cited by 143
TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
Bright, J. J., & Sriram, S. (1998) · PubMed · Cited by 126
Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets
Roda, J. M., Parihar, R., Lehman, A., Mani, A., Tridandapani, S., & Carson, W. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.120 · Cited by 119
Trotta, R., Puorro, K. A., Paroli, M., Azzoni, L., Abebe, B., Eisenlohr, L. C., & PERUSSIA, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6648 · Cited by 116
Self-citationAzzoni, L., Kamoun, M., Salcedo, T. W., Kanakaraj, P., & Perussia, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1745 · Cited by 106
Khan, K. D., Emmanouilides, C. E., Benson, D. M., Hurst, D., Garcia, P., Michelson, G. C., Milan, S., Ferketich, A. K., Piro, L. D., Leonard, J. P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1571 · Cited by 105
Self-citationGowda, A. C., Roda, J. M., Hussain, S.-R. A., Ramanunni, A., Joshi, T., Schmidt, S., Zhang, X., Lehman, A., Jarjoura, D. G., Carson, W. E., et al. (2008) · Blood · doi:10.1182/blood-2007-07-099531 · Cited by 102
Self-citationPhosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction.
Kanakaraj, P., Duckworth, B. C., Azzoni, L., Kamoun, M., Cantley, L. C., & PERUSSIA, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.2.551 · Cited by 96
Trotta, R., Kanakaraj, P., & PERUSSIA, B. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1027 · Cited by 90
Self-citationRankin, B. M., Yocum, S. A., Mittler, R. S., & Kiener, P. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.605 · Cited by 88
Tridandapani, S., Wardrop, R. M., Baran, C. P., Wang, Y., Opalek, J. M., Caligiuri, M. A., & Marsh, C. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4572 · Cited by 81
Self-citationTrotta, R., Parihar, R., Yu, J., Becknell, B., Allard, J., Wen, J., Ding, W., Mao, H., Tridandapani, S., Carson, W. E., et al. (2004) · Blood · doi:10.1182/blood-2004-10-4072 · Cited by 81
Self-citationThe dual adverse effects of TGF-β secretion on tumor progression
Trapani, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.018 · Cited by 80
Fc Receptors on Natural Killer Cells
PERUSSIA, B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_6 · Cited by 79
Regulation of Natural Killer Cell Activity by Transforming Growth Factor‐β and Prostaglandin E2
Malygin, A. M., Meri, S., & Timonen, T. T. (1993) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1993.tb01667.x · Cited by 77
Trotta, R., Fettucciari, K., Azzoni, L., Abebe, B., Puorro, K. A., Eisenlohr, L. C., & PERUSSIA, B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1782 · Cited by 74
Self-citationBiswas, S., Criswell, T. L., Wang, S. E., & Arteaga, C. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0952 · Cited by 69
Horwitz, D. A., Gray, J. D., & Ohtsuka, K. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00253-1 · Cited by 58
Galandrini, R., Palmieri, G., Piccoli, M., Frati, L., & Santoni, A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.179 · Cited by 53
Human NK cell IFN-γ production is regulated by endogenous TGF-β
Meadows, S. K., Eriksson, M., Barber, A., & Sentman, C. L. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.013 · Cited by 45
Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector
Becknell, B., Trotta, R., Yu, J., Ding, W., Mao, H. C., Hughes, T. L., Marburger, T. B., & Caligiuri, M. A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.11.012 · Cited by 37
Self-citationTranscriptional control of human T‐BET expression: The role of Sp1
Yu, J., Wei, M., Boyd, Z. S., Lehmann, E. B., Trotta, R., Mao, H. C., Liu, S., Becknell, B., Jaung, M., Jarjoura, D. G., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737088 · Cited by 35
Self-citationTGF-β Does Not Inhibit IL-12- and IL-2-Induced Activation of Janus Kinases and STATs
Sudarshan, C., Galon, J., Zhou, Y., & O’Shea, J. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2974 · Cited by 33
TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs.
Sudarshan, C., Galon, J., Zhou, Y., & O’Shea, J. J. (1999) · PubMed · Cited by 32
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Viel, S., Marçais, A., Guimaraes, F. S.-F., Loftus, R., Rabilloud, J., Grau, M., Degouve, S., Djebali, S., Sanlaville, A., Charrier, E., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad1884 · Cited by 672
Metadata
- Authors
- Trotta, R., Col, J. D., Yu, J., Ciarlariello, D., Thomas, B., Zhang, X., Allard, J., Wei, M., Mao, H., Byrd, J. C., Perrotti, D., & Caligiuri, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-09
- Volume
- 181
- Issue
- 6
- Pages
- 3784-3792
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1772986380
- Cited by
- 275
- References
- 54
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.